IP Library Granted Patent US 12,195,765
Granted Patent B2
US 12,195,765 · App. 18/190,775 · Granted Jan 14, 2025

Platforms and systems for automated cell culture

Inventors: Matthias Wagner (Cambridge, MA); Suvi Aivio (Arlington, MA); Mariangela Amenduni (Arlington, MA); Catherine Pilsmaker (Arlington, MA); Arnaldo Pereira (Cambridge, MA); Ananya Zutshi (Boston, MA); Anthia Toure (Boston, MA); Steven Nagle (Wayland, MA); Ozge Whiting (Pawtucket, RI); George Harb (Providence, RI); Matthew Sullivan (Westwood, MA); Maya Berlin-Udi (Acton, MA); Stefanie Morgan (Hanover, MA); Nick Seay (Charlottesville, VA); Sang Lee (Newton, MA); Scott Luro (Somerville, MA)
Assignee: Cellino Biotech, Inc.
C12N5/0696B01L3/502715B01L3/502761B01L9/52C12M23/14C12M23/22C12M23/26C12M23/28C12M23/42C12M23/44C12M23/48C12M25/06C12M27/02C12M29/02C12M31/02C12M33/00C12M33/12C12M41/12C12M41/26C12M41/44C12M41/46C12M41/48C12M47/04C12N5/0081G01N15/1023G01N15/1429G01N15/1433G01N15/1434G06T7/0012G06T7/0016B01L2200/18B01L2300/0663B01L2300/0877C12M41/36G01N2015/1006G01N2015/1452G01N2015/1454G01N2015/1486G06T2207/10056G06T2207/10064G06T2207/20081G06T2207/30024G06T2207/30072
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,195,765
App. No.
18/190,775
Granted
Jan 14, 2025
Kind
B2
Abstract

Disclosed herein are platforms, systems, and methods including a cell culture system that includes a cell culture container comprising a cell culture, the cell culture receiving input cells, a cell imaging subsystem configured to acquire images of the cell culture, a computing subsystem configured to perform a cell culture process on the cell culture according to the images acquired by the cell imaging subsystem, and a cell editing subsystem configured to edit the cell culture to produce output cell products according to the cell culture process.

Claims (49)

1. A method for producing an induced pluripotent stem cell (iPSC) product, comprising:

(a) culturing a plurality of iPSC candidate cells in a closed cell culture container, wherein a plurality of iPSC candidate cell colonies emerge from the plurality of iPSC candidate cells;

(b) acquiring, using an image sensor, time-series image data of the plurality of iPSC candidate cell colonies;

(c) processing, by a computer processor, the acquired time-series image data using one or more trained machine learning models to predict clonal quality of the plurality of iPSC candidate cell colonies;

(d) managing, by a cell editing subsystem, the plurality of iPSC candidate cell colonies based at least in part on the acquired time-series image data, wherein managing the plurality of iPSC candidate cell colonies comprises performing selective removal of at least a portion of an iPSC candidate cell colony of the plurality of iPSC candidate colonies based at least in part on whether the iPSC candidate cell colony will collide with another iPSC candidate cell colony of the plurality of iPSC candidate cell colonies;

(e) selecting, by the computer processor, at least one of the plurality of iPSC candidate cell colonies for expansion based at least in part on the predicted clonal quality of the plurality of iPSC candidate cell colonies;

(f) removing, by the cell editing subsystem, non-selected iPSC candidate cell colonies of the plurality of iPSC candidate cell colonies from the closed cell culture container; and

(g) expanding the selected at least one of the iPSC candidate cell colonies into the iPSC product.

2. The method of claim 1 , further comprising further training the one or more trained machine learning models using iPSC assay data.

3. The method of claim 2 , wherein the iPSC assay data is acquired from a previously expanded iPSC product.

4. The method of claim 1 , further comprising performing one or more additional iterations of (b) to (f).

5. The method of claim 1 , wherein processing the acquired time-series image data using the one or more trained machine learning models to predict the clonal quality of the plurality of iPSC candidate cell colonies further comprises identifying one or more phenotypic features of the plurality of iPSC candidate cell colonies.

6. The method of claim 1 , wherein the closed cell culture container comprises a cell culture chamber having a first semi-transparent surface, the first semi-transparent surface comprising a laser-activated film.

7. The method of claim 6 , wherein the plurality of iPSC candidate cells are adhered to the first semi-transparent surface.

8. The method of claim 6 , wherein the laser-activated film transmits incident light in a first range of wavelengths and absorbs incident light in a second range of wavelengths.

9. The method of claim 8 , further comprising imaging cells within the cell culture chamber using incident light in the first range of wavelengths, and editing cells within the cell culture chamber using incident light in the second range of wavelengths.

10. The method of claim 1 , wherein the iPSC product is suitable for differentiation into a target cell type.

11. The method of claim 1 , wherein the selected at least one of the iPSC candidate cell colonies are clonal cell colonies, and wherein the iPSC product is a monoclonal iPSC product.

12. A system for producing an induced pluripotent stem cell (iPSC) product, comprising:

a closed cell culture container configured to culture a plurality of iPSC candidate cells, wherein a plurality of iPSC candidate cell colonies emerge from the plurality of iPSC candidate cells;

an image sensor configured to acquire time-series image data of the plurality of iPSC candidate cell colonies;

a computer processor programmed to:

process the acquired time-series image data using one or more trained machine learning models to predict clonal quality of the plurality of iPSC candidate cell colonies; and

select at least one of the plurality of iPSC candidate cell colonies for expansion based at least in part on the predicted clonal quality of the plurality of iPSC candidate cell colonies; and

a cell editing subsystem configured to:

manage the plurality of iPSC candidate cell colonies based at least in part on the acquired time-series image data, wherein managing the plurality of iPSC candidate cell colonies comprises performing selective removal of at least a portion of an iPSC candidate cell colony of the plurality of iPSC candidate colonies based at least in part on whether the iPSC candidate cell colony will collide with another iPSC candidate cell colony of the plurality of iPSC candidate cell colonies; and

remove non-selected iPSC candidate cell colonies of the plurality of iPSC candidate cell colonies from the closed cell culture container, wherein the selected at least one of the iPSC candidate cell colonies expand into the iPSC product.

13. The system of claim 12 , wherein the one or more trained machine learning models are further trained based on iPSC assay data.

14. The system of claim 12 , wherein processing the acquired time-series image data using the one or more trained machine learning models to predict the clonal quality of the plurality of iPSC candidate cell colonies further comprises identifying one or more phenotypic features of the plurality of iPSC candidate cell colonies.

15. The system of claim 12 , wherein the closed cell culture container comprises a cell culture chamber having a first semi-transparent surface, the first semi-transparent surface comprising a laser-activated film.

16. The system of claim 15 , wherein the plurality of iPSC candidate cells are adhered to the first semi-transparent surface.

17. The system of claim 15 , wherein the laser-activated film is configured to transmit incident light in a first range of wavelengths and absorb incident light in a second range of wavelengths.

18. The system of claim 17 , wherein the first range of wavelengths enables imaging cells within the cell culture chamber, and wherein the second range of wavelengths enables editing cells within the cell culture chamber.

19. The system of claim 12 , wherein the iPSC product is suitable for differentiation into a target cell type.

20. The system of claim 12 , wherein the selected at least one of the iPSC candidate cell colonies are clonal cell colonies, and wherein the iPSC product is a monoclonal iPSC product.

21. The method of claim 1 , wherein managing the plurality of iPSC candidate cell colonies further comprises at least one of fragmenting a first iPSC candidate cell colony into a plurality of sub-colonies, and removing at least a portion of the first iPSC candidate cell colony to reduce its confluence or density.

22. The method of claim 21 , wherein managing the plurality of iPSC candidate cell colonies further comprises at least one of:

(i) removing the first iPSC candidate cell colony based at least in part on whether the first iPSC candidate cell colony is growing outside of a designated growth region of the closed cell culture container,

(ii) removing non-induced pluripotent stem cells from the closed cell culture container, and

(iii) removing neighboring cells in a zone around the first iPSC candidate cell colony.

23. The method of claim 1 , wherein processing the acquired time-series image data using the one or more trained machine learning models to predict clonal quality of the plurality of iPSC candidate cell colonies further comprises generating an outcome score for each of the iPSC candidate cell colonies that represents a likelihood that each iPSC candidate cell colony produces a desired output cell product.

24. The system of claim 12 , wherein managing the plurality of iPSC candidate cell colonies further comprises at least one of fragmenting a first iPSC candidate cell colony into a plurality of sub-colonies, and removing at least a portion of the first iPSC candidate cell colony to reduce its confluence or density.

25. The system of claim 24 , wherein managing the plurality of iPSC candidate cell colonies further comprises at least one of:

(i) removing the first iPSC candidate cell colony based at least in part on whether the first iPSC candidate cell colony is growing outside of a designated growth region of the closed cell culture container,

(ii) removing non-induced pluripotent stem cells from the closed cell culture container, and

(iii) removing neighboring cells in a zone around the first iPSC candidate cell colony.

26. The system of claim 12 , wherein processing the acquired time-series image data using the one or more trained machine learning models to predict clonal quality of the plurality of iPSC candidate cell colonies further comprises generating an outcome score for each of the iPSC candidate cell colonies that represents a likelihood that each iPSC candidate cell colony produces a desired output cell product.

27. The method of claim 1 , wherein the selective removal of the cells in the plurality of iPSC candidate cell colonies comprises lysing the cells.

28. The system of claim 12 , wherein the selective removal of the cells in the plurality of iPSC candidate cell colonies comprises lysing the cells.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2023
From: WAGNER, MATTHIAS; AIVIO, SUVI; AMENDUNI, MARIANGELA; PILSMAKER, CATHERINE; PEREIRA, ARNALDO; ZUTSHI, ANANYA; TOURE, ANTHIA; NAGLE, STEVEN; WHITING, OZGE; HARB, GEORGE; SULLIVAN, MATTHEW; BERLIN-UDI, MAYA; MORGAN, STEFANIE; SEAY, NICK; LEE, SANG; LURO, SCOTT
To: CELLINO BIOTECH, INC.
Reel/Frame 063178/0112 →
Continuity (19)
Continuation 17688859 · Mar 7, 2022
Provisional Application 63311673 · Feb 18, 2022
Provisional Application 63298241 · Jan 11, 2022
Provisional Application 63297290 · Jan 7, 2022
Provisional Application 63295968 · Jan 3, 2022
Provisional Application 63288859 · Dec 13, 2021
Provisional Application 63284839 · Dec 1, 2021
Provisional Application 63282351 · Nov 23, 2021
Provisional Application 63249698 · Sep 29, 2021
Provisional Application 63239995 · Sep 2, 2021
Provisional Application 63226128 · Jul 27, 2021
Provisional Application 63222059 · Jul 15, 2021
Provisional Application 63216558 · Jun 30, 2021
Provisional Application 63210243 · Jun 14, 2021
Provisional Application 63196904 · Jun 4, 2021
Provisional Application 63194306 · May 28, 2021
Provisional Application 63167114 · Mar 28, 2021
Provisional Application 63157731 · Mar 7, 2021
Related Publication 20230235295A1 · Jul 27, 2023
References Cited (164)
US 5900374A · Otto-Nagels · 1999 [cited by applicant]
US 6096532A · Armstrong et al. · 2000 [cited by applicant]
US 6153400A · Matsumura et al. · 2000 [cited by applicant]
US 6673008B1 · Thompson et al. · 2004 [cited by applicant]
US 7754148B2 · Yu et al. · 2010 [cited by applicant]
US 8492140B2 · Smith et al. · 2013 [cited by applicant]
US 8546142B2 · Martin et al. · 2013 [cited by applicant]
US 9181529B2 · Kattman et al. · 2015 [cited by applicant]
US 9499780B2 · Smith et al. · 2016 [cited by applicant]
US 9783768B2 · Larcher et al. · 2017 [cited by applicant]
US 10078075B2 · Wikswo et al. · 2018 [cited by applicant]
US 10829729B2 · Mazur et al. · 2020 [cited by applicant]
US 10876086B2 · Suzuki et al. · 2020 [cited by applicant]
US 11028358B2 · Kelso et al. · 2021 [cited by applicant]
US 11866735B2 · Wagner et al. · 2024 [cited by applicant]
US 11913029B2 · Wagner et al. · 2024 [cited by applicant]
US 11931737B2 · Wagner et al. · 2024 [cited by applicant]
US 20020055166A1 · Cannon et al. · 2002 [cited by applicant]
US 20030039384A1 · Bacus · 2003 [cited by applicant]
US 20030040104A1 · Barbera-Guillem · 2003 [cited by applicant]
US 20030054335A1 · Taya et al. · 2003 [cited by applicant]
US 20030068814A1 · Malinge · 2003 [cited by applicant]
US 20050026221A1 · Richmond et al. · 2005 [cited by applicant]
US 20070163963A1 · Faustman · 2007 [cited by examiner]
US 20070212747A1 · Browne et al. · 2007 [cited by applicant]
US 20070292312A1 · Bachman et al. · 2007 [cited by applicant]
US 20090258417A1 · Tanaka et al. · 2009 [cited by applicant]
US 20090286317A1 · Demmler et al. · 2009 [cited by applicant]
US 20120130287A1 · Gruber · 2012 [cited by examiner]
US 20120208273A1 · Tarunina et al. · 2012 [cited by applicant]
US 20120294836A1 · Rowley et al. · 2012 [cited by applicant]
US 20120315620A1 · Watakabe · 2012 [cited by examiner]
US 20120329123A1 · Nakashima et al. · 2012 [cited by applicant]
US 20130102772A1 · Eshima et al. · 2013 [cited by applicant]
US 20130169969A1 · Popescu et al. · 2013 [cited by applicant]
US 20130337492A1 · Axelrod et al. · 2013 [cited by applicant]
US 20140004507A1 · Malic et al. · 2014 [cited by applicant]
US 20140030805A1 · Kasuto et al. · 2014 [cited by applicant]
US 20150107995A1 · Sista et al. · 2015 [cited by applicant]
US 20160177244A1 · Conway et al. · 2016 [cited by applicant]
US 20160195523A1 · Chatterjee et al. · 2016 [cited by applicant]
US 20160237392A1 · Lee · 2016 [cited by applicant]
US 20170009252A1 · Baylink et al. · 2017 [cited by applicant]
US 20170014824A1 · Boyd et al. · 2017 [cited by applicant]
US 20170029864A1 · Straus · 2017 [cited by applicant]
US 20180072975A1 · Aviles et al. · 2018 [cited by applicant]
US 20180087021A1 · Blanchard · 2018 [cited by applicant]
US 20180321128A1 · Harriman et al. · 2018 [cited by applicant]
US 20190009274A1 · Novak et al. · 2019 [cited by applicant]
US 20190071695A1 · Wagner et al. · 2019 [cited by applicant]
US 20190169572A1 · Shi et al. · 2019 [cited by applicant]
US 20190352589A1 · Jing et al. · 2019 [cited by applicant]
US 20200087607A1 · Magnant · 2020 [cited by applicant]
US 20200131465A1 · Floto et al. · 2020 [cited by applicant]
US 20200141961A1 · Ahlfors · 2020 [cited by applicant]
US 20200200781A1 · Smith et al. · 2020 [cited by applicant]
US 20200208095A1 · Oram et al. · 2020 [cited by applicant]
US 20200318053A1 · Kojima et al. · 2020 [cited by applicant]
US 20210123008A1 · Trainor et al. · 2021 [cited by applicant]
US 20210253991A1 · Kelso et al. · 2021 [cited by applicant]
US 20210261899A1 · Blanchard · 2021 [cited by applicant]
US 20210283606A1 · Thakkar et al. · 2021 [cited by applicant]
US 20210317399A1 · Nazareth · 2021 [cited by examiner]
US 20210403942A1 · Wang et al. · 2021 [cited by applicant]
US 20220106549A1 · Magnant · 2022 [cited by applicant]
US 20220107488A1 · Berns et al. · 2022 [cited by applicant]
US 20220226814A1 · Iida et al. · 2022 [cited by applicant]
US 20220276463A1 · Hunt et al. · 2022 [cited by applicant]
US 20220282201A1 · Wagner et al. · 2022 [cited by applicant]
US 20220282202A1 · Wagner et al. · 2022 [cited by applicant]
US 20220282203A1 · Wagner et al. · 2022 [cited by applicant]
US 20220282223A1 · Wagner et al. · 2022 [cited by applicant]
US 20220284574A1 · Wagner et al. · 2022 [cited by applicant]
US 20230065504A1 · Wagner et al. · 2023 [cited by applicant]
US 20230095664A1 · Wagner et al. · 2023 [cited by applicant]
US 20230265394A1 · Wagner et al. · 2023 [cited by applicant]
US 20230332111A1 · Wagner et al. · 2023 [cited by applicant]
CN 105492888B · 2018 [cited by applicant]
CN 113421221A · 2021 [cited by examiner]
EP 3556841A1 · 2019 [cited by applicant]
JP 2013179916A · 2013 [cited by applicant]
KR 20070012514A · 2007 [cited by applicant]
WO WO2007052716A1 · 2007 [cited by applicant]
WO WO2011132584A1 · 2011 [cited by applicant]
WO WO2016114438A1 · 2016 [cited by applicant]
WO WO2017079682A1 · 2017 [cited by applicant]
WO WO2019178561A2 · 2019 [cited by applicant]
WO WO2019241885A1 · 2019 [cited by applicant]
WO WO2020033871A1 · 2020 [cited by applicant]
WO WO2020097083A1 · 2020 [cited by examiner]
WO WO2021150631A1 · 2021 [cited by examiner]
WO WO2022096315A1 · 2022 [cited by applicant]
WO WO2022192157A1 · 2022 [cited by applicant]
WO WO2023055543A1 · 2023 [cited by applicant]
Aasen et al.: Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Nat Protoc. 2010 5(2):371-382 doi:10.1038/nprot.2009.241 (2010). [cited by applicant]
Ahmed et al.: In situ self-assembly of gold nanoparticles on hydrophilic and hydrophobic substrates for influenza virus-sensing platform. Sci Rep. 7:44495: 1-11 doi:10.1038/srep44495 (2017). [cited by applicant]
Ban et al.: Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci USA 108(34):14234-14239 doi:10.1073/pnas.1103509108 (2011… [cited by applicant]
Bar-Nur et al. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet Beta cells. Cell Stem Cell 9:17-23 (2011). [cited by applicant]
Chen et al.: Nanofabrication by electron beam lithography and its applications: A review. Microelectronic Engineering 135:57-72 https://doi.org/10.1016/j.mee.2015.02.042 (2015). [cited by applicant]
Drews et al.: The cytotoxic and immunogenic hurdles associated with non-viral mRNA-mediated reprogramming of human fibroblasts. Biomaterials 33(16):4059-4068 doi:10.1016/j.biomaterials.2012.02.025 (2012). [cited by applicant]
Drozd et al., Generation of Human iPSCs From Cells of Fibroblastic and Epithelial Origin by Means of the oriP/EBNA-1 Episomal Reprogramming System. Stem Cell Res Ther 6 (1): 122 (2015). [cited by applicant]
Gill et al.: Progress and prospects: the design and production of plasmid vectors. Gene Ther. 16(2):165-171 doi:10.1038/gt.2008.183 (2009). [cited by applicant]
He et al.: Single-shot aperture-scanning Fourier ptychography. Opt Express 26(22):28187-28196 doi:10.1364/OE.26.028187 (2018). [cited by applicant]
Hu et al.: Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine. Biomark Res. 2:3:1-13 doi: 10.1186/2050-7771-2-3 (2014). [cited by applicant]
Hudin et al.: Localized Tactile Stimulation by Time-Reversal of Flexural Waves: Case Study With a Thin Sheet of Glass. IEEE World Haptics Conference, pp. 1-6 DOI:10.1109/WHC.2013.6548386 (2013). [cited by applicant]
Jingshan et al.: Transport of Intensity phase imaging by intensity spectrum fitting of exponentially spaced defocus planes. Opt Express. 22(9):10661-10674 doi:10.1364/OE.22.010661 (2014). [cited by applicant]
Jo et al.: Quantitative Phase Imaging and Artificial Intelligence: A Review. IEEE Journal of Selected Topics in Quantum Electronics 25(1):1-14 (2019). [cited by applicant]
Kashyap et al.: Selective local lysis and sampling of live cells for nucleic acid analysis using a microfluidic probe. Sci Rep. 6:29579:1-10 doi:10.1038/srep29579 (2016). [cited by applicant]
Kim et al.: Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 5;4(6):472-476 doi:10.1016/j.stem.2009.05.005 (2009). [cited by applicant]
Kim et al.: Generation of human induced pluripotent stem cells from osteoarthritis patient-derived synovial cells. Arthritis Rheum 63(10):3010-3021 doi:10.1002/art.30488 (2011). [cited by applicant]
Kogler et al.: Comparison of time-gated surface-enhanced raman spectroscopy (TG-SERS) and classical SERS based monitoring of [cited by applicant]
Lee et al.: Single-shot phase retrieval via Fourier ptychographic microscopy. Optica 5(8):976-983 https://doi.org/10.1364/OPTICA.5.000976 (2018). [cited by applicant]
Li et al.: Excitable networks controlling cell migration during development and disease. Semin Cell Dev Biol. 100:133-142 doi:10.1016/j.semcdb.2019.11.001 (2020). [cited by applicant]
Loh, et al. Reprogramming of T Cells from Human Peripheral Blood. Cell Stem Cell. Jul. 2, 2010; 7(1): 15-19. [cited by applicant]
Lopatynskyi et al.: Au nanostructure arrays for plasmonic applications: annealed island films versus nanoimprint lithography. Nanoscale Res Lett. 10:99: 1-9 doi:10.1186/s11671-015-0819-1 (2015). [cited by applicant]
MANN: Rapid isolation of antigen-specific clones from hybridoma fusions. Nat Methods 4, i-ii URL:https://doi.org/10.1038/nmeth1028 (2007). [cited by applicant]
Meier et al.: Fast electrically assisted regeneration of on chip SERS substrates. Lab on a Chip 15:2923-2927 DOI:10.1039/C5LC00397K (2015). [cited by applicant]
Okita et al.: A more efficient method to generate integration-free human iPS cells. Nat Methods 8(5):409-412 doi:10.1038/nmeth.1591 (2011). [cited by applicant]
Okita et al.: Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nature Protocols 5(3):418-428 (2010). [cited by applicant]
PCT/US2022/019196 International Search Report and Written Opinion dated Jun. 1, 2022. [cited by applicant]
PCT/US2022/042811 International Search Report and Written Opinion dated Nov. 22, 2022. [cited by applicant]
Rim et al.: Chondrogenic Differentiation from Induced Pluripotent Stem Cells Using Non-Viral Minicircle Vectors. Cells 9(3):582:1-21 doi: 10.3390/cells9030582 (2020). [cited by applicant]
Sanchez-Esquivel et al.: Spectral dependence of nonlinear absorption in ordered silver metallic nanoprism arrays. Sci Rep. 7(1):5307:1-9 doi:10.1038/s41598-017-04814-2 (2017). [cited by applicant]
Segalman: Patterning with block copolymer thin films. Materials Science and Engineering R Reports 48(6):191-226 DOI:10.1016/j.mser.2004.12.003 (2005). [cited by applicant]
Skorik et al.: Xeno-Free Reprogramming of Peripheral Blood Mononuclear Erythroblasts on Laminin-521. Curr Protoc Stem Cell Biol. 52(1):e103:1-41 doi:10.1002/cpsc.103 (2020). [cited by applicant]
Stewart et al.: Intracellular Delivery by Membrane Disruption: Mechanisms, Strategies, and Concepts. Chem Rev. 118(16):7409-7531 doi:10.1021/acs.chemrev.7b00678 (2018). [cited by applicant]
Takahasi et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861-872 doi:10.1016/j.cell.2007.11.019 (2007). [cited by applicant]
Thiers: Dermatology and Dermatologic Surgery. Chapter 15—Miscellaneous Topics in Clinical Dermatology, Elsevier—Health Sciences Division, pp. 302-303 (2008). [cited by applicant]
Tvarozek et al.: Plasmonic behaviour of sputtered Au nanoisland arrays. Applied Surface Science 395:241-247 DOI:10.1016/j.apsusc.2016.04.183 (2017). [cited by applicant]
U.S. Appl. No. 17/688,837 Final Office Action dated Oct. 5, 2022. [cited by applicant]
U.S. Appl. No. 17/688,837 Non-Final Office Action dated May 26, 2022. [cited by applicant]
U.S. Appl. No. 17/688,854 Non-Final Office Action dated May 11, 2022. [cited by applicant]
U.S. Appl. No. 17/688,857 Final Office Action dated Oct. 14, 2022. [cited by applicant]
U.S. Appl. No. 17/688,857 Non-Final Office Action dated Jun. 9, 2022. [cited by applicant]
U.S. Appl. No. 17/688,859 Final Office Action dated Sep. 27, 2022. [cited by applicant]
U.S. Appl. No. 17/688,859 Non-Final Office Action dated Jun. 10, 2022. [cited by applicant]
U.S. Appl. No. 17/688,861 Final Office Action dated Nov. 7, 2022. [cited by applicant]
U.S. Appl. No. 17/688,861 Non-Final Office Action dated Jun. 24, 2022. [cited by applicant]
U.S. Appl. No. 17/930,413 Non-Final Office Action dated Jan. 26, 2023. [cited by applicant]
U.S. Appl. No. 17/930,413 Non-Final Office Action dated Nov. 30, 2022. [cited by applicant]
U.S. Appl. No. 18/061,811 Non-Final Office Action dated Jan. 12, 2023. [cited by applicant]
Warren et al., Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7(5):618-630 (2010). [cited by applicant]
Watt et al.: Ion beam lithography and nanofabrication: A review. International Journal of Nanoscience 4(3):269-286 DOI:10.1142/S0219581X05003139 (2005). [cited by applicant]
Yoshioka et al.: Efficient generation of human iPSCs by a synthetic self-replicative RNA. Cell Stem Cell 13(2):246-254 doi:10.1016/j.stem.2013.06.001 (2013). [cited by applicant]
Zheng et al.: Concept, implementations and applications of Fourier ptychography. Nature Physics Reviews 3(3):207-223 DOI:10.1038/s42254-021-00280-y (2021). [cited by applicant]
Zhou et al.: Generation of induced pluripotent stem cells from urine. J Am Soc Nephrol. 22(7):1221-1228 doi:10.1681/ASN.2011010106 (2011). [cited by applicant]
Zhou et al.: Integration-free Methods for Generating Induced Pluripotent Stem Cells. Genomics, Proteomics & Bioinformatics 11(5):284-287 (2013). [cited by applicant]
Zhou et al.: Si surface passivation by SiOx : H films deposited by a low-frequency ICP for solar cell applications. Journal of Physics D Applied Physics 45(39):395401, pp. 1-8 DOI:10.1088/0022-3727/45/39/395401 (2012). [cited by applicant]
Zou et al.: High-resolution transport-of-intensity quantitative phase microscopy with annular illumination. arXiv:1704.04091v3 [physics.optics], pp. 1-25 doi: 10.48550/ARXIV.1704.04091 (2017). [cited by applicant]
Zou et al.: High-resolution transport-of-intensity quantitative phase microscopy with annular illumination. Sci Rep. 7(1):7654, pp. 1-22 doi:10.1038/s41598-017-06837-1 (2017). [cited by applicant]
Zuo et al.: Transport of intensity equation: a tutorial. Optics and Lasers in Engineering 135(106187):1-98 URL:https://doi.org/10.1016/j.optlaseng.2020.106187 (2020). [cited by applicant]
U.S. Appl. No. 17/688,854 Non-Final Office Action dated Apr. 21, 2023. [cited by applicant]
U.S. Appl. No. 17/688,861 Non-Final Office Action dated May 11, 2023. [cited by applicant]
U.S. Appl. No. 17/930,413 Final Office Action dated May 26, 2023. [cited by applicant]
U.S. Appl. No. 18/061,811 Final Office Action dated Apr. 21, 2023. [cited by applicant]
U.S. Appl. No. 17/688,837 Non-Final Office Action dated Apr. 6, 2023. [cited by applicant]
Kulik et al.: Parallelization in automated stem cell culture. 3rd CIRP Conference on BioManufacturing, Procedia CIRP 65:242-247 (2017). [cited by applicant]
Co-pending U.S. Appl. No. 18/391,002, inventors Wagner; Matthias et al., filed Dec. 20, 2023. [cited by applicant]
Co-pending U.S. Appl. No. 18/391,053, inventors Wagner; Matthias et al., filed Dec. 20, 2023. [cited by applicant]
U.S. Appl. No. 17/688,854 Final Office Action dated Aug. 1, 2023. [cited by applicant]
U.S. Appl. No. 17/688,861 Final Office Action dated Oct. 12, 2023. [cited by applicant]
U.S. Appl. No. 17/930,413 Office Action dated Aug. 25, 2023. [cited by applicant]
U.S. Appl. No. 18/339,779 Office Action dated Mar. 13, 2024. [cited by applicant]
U.S. Appl. No. 18/061,811 Office Action dated Aug. 15, 2023. [cited by applicant]